Research ArticleOriginal Article
Open Access

Natural immunity to influenza A and B among Saudi blood donors in Al Madinah Al Munawarah, Saudi Arabia

Waleed H. Mahallawi, Nadir A. Ibrahim, Khalid S. Alahmadi, Abdullah K. Al-Harbi, Mohammed A. Almughthawi, Omar A. Alhazmi, Fayez H. Alsehli and Omar F. Khabour
Saudi Medical Journal December 2020, 41 (12) 1301-1307; DOI: https://doi.org/10.15537/smj.2020.12.05582

References

  1. ↵
    1. Kim H,
    2. Webster RG,
    3. Webby RJ
    (2018) Influenza virus: dealing with a drifting and shifting pathogen. Viral Immunol 31:174–183.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Ryan EL,
    2. Hollingworth R,
    3. Grand RJ
    (2016) Activation of the DNA damage response by RNA viruses. Biomolecules 6:2.
    OpenUrlCrossRef
  3. ↵
    1. Yang G,
    2. Hodges EN,
    3. Winter J,
    4. Zanders N,
    5. Shcherbik S,
    6. Bousse T,
    7. et al.
    (2020) Development of an RNA strand-specific hybridization assay to differentiate replicating versus non-replicating influenza A virus. Journal of clinical microbiology.
  4. ↵
    1. Iuliano AD,
    2. Roguski KM,
    3. Chang HH,
    4. Muscatello DJ,
    5. Palekar R,
    6. Tempia S,
    7. et al.
    (2018) Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391:1285–1300.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Lee VJ,
    2. Ho ZJM,
    3. Goh EH,
    4. Campbell H,
    5. Cohen C,
    6. Cozza V,
    7. et al.
    (2018) Advances in measuring influenza burden of disease. Influenza Other Respir Viruses 12:3–9.
    OpenUrlCrossRef
  6. ↵
    1. Krammer F,
    2. Smith GJD,
    3. Fouchier RAM,
    4. Peiris M,
    5. Kedzierska K,
    6. Doherty PC,
    7. et al.
    (2018) Influenza. Nat Rev Dis Primers 4:3.
    OpenUrlPubMed
  7. ↵
    1. Paget J,
    2. Spreeuwenberg P,
    3. Charu V,
    4. Taylor RJ,
    5. Iuliano AD,
    6. Bresee J,
    7. et al.
    (2019) Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR Project. J Glob Health 9:020421.
    OpenUrl
  8. ↵
    1. Sellers SA,
    2. Hagan RS,
    3. Hayden FG,
    4. Fischer WA 2nd.
    (2017) The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses 11:372–393.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Hirve S,
    2. Lambach P,
    3. Paget J,
    4. Vandemaele K,
    5. Fitzner J,
    6. Zhang W
    (2016) Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review. Influenza Other Respir Viruses 10:254–267.
    OpenUrl
  10. ↵
    1. Mahallawi WH
    (2017) Assessment of the influenza vaccine (VAXIGRIP) in triggering a humoural immune response. J Taibah Univ Med Sci 12:523–527.
    OpenUrl
  11. ↵
    1. Chen YQ,
    2. Wohlbold TJ,
    3. Zheng NY,
    4. Huang M,
    5. Huang Y,
    6. Neu KE,
    7. et al.
    (2018) Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies. Cell 173:417–429.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Krammer F
    (2019) The human antibody response to influenza A virus infection and vaccination. Nat Rev Immunol 19:383–397.
    OpenUrl
  13. ↵
    1. McVernon J,
    2. Laurie K,
    3. Faddy H,
    4. Irving D,
    5. Nolan T,
    6. Barr I,
    7. et al.
    (2014) Seroprevalence of antibody to influenza A (H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia. Influenza Other Respir Viruses 8:194–200.
    OpenUrl
  14. ↵
    1. Krumbholz A,
    2. Lange J,
    3. Dürrwald R,
    4. Walther M,
    5. Müller TH,
    6. Kühnel D,
    7. et al.
    (2014) Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany. Med Microbiol Immunol 203:13–24.
    OpenUrl
  15. ↵
    1. Andersen CJ,
    2. Murphy KE,
    3. Fernandez ML
    (2016) Impact of obesity and metabolic syndrome on immunity. Adv Nutr 7:66–75.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Honce R,
    2. Schultz-Cherry S
    (2019) Impact of obesity on Influenza A virus pathogenesis, immune response, and evolution. Front Immunol 10:1071.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Green WD,
    2. Beck MA
    (2017) Obesity impairs the adaptive immune response to influenza virus. Ann Am Thorac Soc 14:S406–S409.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Alomari MA,
    2. Khabour OF,
    3. Alzoubi KH
    (2020) Metabolic differences between men and women who are long-term users of the water pipe: The Irbid WiHi project. J Vasc Nurs 38:18–24.
    OpenUrl
  19. ↵
    1. Alsuwaidi AR,
    2. Al-Mekaini LA,
    3. Kamal SM,
    4. Narchi H,
    5. Souid AK
    (2017) Seroprevalence of influenza A and B viruses among unvaccinated children in the United Arab Emirates: a cross-sectional study. BMC Res Notes 10:379.
    OpenUrl
  20. ↵
    1. Caini S,
    2. El-Guerche Séblain C,
    3. Ciblak MA,
    4. Paget J
    (2018) Epidemiology of seasonal influenza in the Middle East and North Africa regions, 2010-2016: circulating influenza A and B viruses and spatial timing of epidemics. Influenza Other Respir Viruses 12:344–352.
    OpenUrl
  21. ↵
    1. Abdalla O,
    2. Mohammed M,
    3. Hakawi AM,
    4. Aljifri A,
    5. Abdalla M,
    6. Eltigani S,
    7. et al.
    (2020) Hospital-based surveillance of influenza A (H1N1) pdm09 virus in Saudi Arabia, 2010-2016. Ann Saudi Med 40:1–6.
    OpenUrl
  22. ↵
    1. Alrashid M,
    2. Taleb AA,
    3. Hajeer A,
    4. Arabi Y
    (2017) Prevalence of antibodies against the Middle East respiratory syndrome coronavirus, influenza A and B viruses among blood donors, Saudi Arabia. Ann Thorac Med 12:217–218.
    OpenUrl
  23. ↵
    1. Su S,
    2. Chaves SS,
    3. Perez A,
    4. D'Mello T,
    5. Kirley PD,
    6. Yousey-Hindes K,
    7. et al.
    (2014) Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection. Clin Infect Dis 59:252–255.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Muñoz IS,
    2. Rello SR,
    3. Lejarazu RO
    (2018) [Prevalence of antibodies and humoral response after seasonal trivalent vaccination against influenza B lineages in an elderly population of Spain]. Enferm Infecc Microbiol Clin 36:572–575, In Spanish.
    OpenUrl
  25. ↵
    1. Gaglani M,
    2. Vasudevan A,
    3. Raiyani C,
    4. Murthy K,
    5. Chen W,
    6. Reis M,
    7. et al.
    (2020) Effectiveness of trivalent and quadrivalent inactivated vaccines against influenza B in the United States, 2011-2012 to 2016-2017. Clin Infect Dis, ciaa102.
    1. Vijaykrishna D,
    2. Holmes EC,
    3. Joseph U,
    4. Fourment M,
    5. Su YC,
    6. Halpin R,
    7. et al.
    (2015) The contrasting phylodynamics of human influenza B viruses. Elife 4:e05055.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Skowronski DM,
    2. Chambers C,
    3. De Serres G,
    4. Sabaiduc S,
    5. Winter AL,
    6. Dickinson JA,
    7. et al.
    (2017) Age-related differences in influenza B infection by lineage in a community-based sentinel system, 2010-2011 to 2015-2016, Canada. J Infect Dis 216:697–702.
    OpenUrlCrossRef
  28. ↵
    1. Xie H,
    2. Wan XF,
    3. Ye Z,
    4. Plant EP,
    5. Zhao Y,
    6. Xu Y,
    7. et al.
    (2015) H3N2 mismatch of 2014-15 northern hemisphere influenza vaccines and head-to-head comparison between human and ferret antisera derived antigenic maps. Sci Rep 5:15279.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Hensley SE
    (2014) Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Curr Opin Virol 8:85–89.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Rabaan AA,
    2. Alshaikh SA,
    3. Bazzi AM
    (2018) Influenza A (H1N1) pdm09 epidemiology in the Eastern Province of Saudi Arabia. J Infect Public Health 11:636–639.
    OpenUrl
  31. ↵
    1. Van Kerkhove MD,
    2. Hirve S,
    3. Koukounari A,
    4. Mounts AW
    (2013) Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza Other Respir Viruses 7:872–886.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Dobner J,
    2. Kaser S
    (2018) Body mass index and the risk of infection - from underweight to obesity. Clin Microbiol Infect 24:24–28.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Alfelali M,
    2. Barasheed O,
    3. Tashani M,
    4. Azeem MI,
    5. El Bashir H,
    6. Memish ZA,
    7. et al.
    (2015) Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: a 10-year retrospective analysis of data. Vaccine 33:2562–2569.
    OpenUrl
    1. Al-Tawfiq JA,
    2. Benkouiten S,
    3. Memish ZA
    (2018) A systematic review of emerging respiratory viruses at the Hajj and possible coinfection with streptococcus pneumoniae. Travel Med Infect Dis 23:6–13.
    OpenUrl
    1. Benkouiten S,
    2. Charrel R,
    3. Belhouchat K,
    4. Drali T,
    5. Nougairede A,
    6. Salez N,
    7. et al.
    (2014) Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis 20:1821–1827.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Benkouiten S,
    2. Gautret P,
    3. Belhouchat K,
    4. Drali T,
    5. Nougairede A,
    6. Salez N,
    7. et al.
    (2015) Comparison of nasal swabs with throat swabs for the detection of respiratory viruses by real-time reverse transcriptase PCR in adult Hajj pilgrims. J Infect 70:207–210.
    OpenUrlCrossRef
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords